COVID-19 Antithrombotic Rivaroxaban Evaluation
Clinical trial NCT04757857 · TERMINATED
Trial details
- NCT number
- NCT04757857
- Sponsor
- Hospital Alemão Oswaldo Cruz
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-29
- Primary completion
- 2022-08-08
- Enrollment
- 660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.